AMMAN — The Ministry of Health signed a memorandum
of understanding with the American Chamber of Commerce in Jordan and a
gathering of 15 international pharmaceutical research companies operating in
the Kingdom, according to the Jordan News Agency, Petra.
اضافة اعلان
The memorandum aims at improving health care services and
patients' access to innovative treatments. It includes the establishment of a joint
committee to build and develop medical cadres in rare specialties, train them
on the foundations and methods of scientific research, and patient access to
the latest scientific findings in medical treatment options.
The memorandum was signed by the Minister of Health, Dr.
Firas Al-Hawari, the chamber's president, Muhammad Batayneh, and the head of
the gathered pharmaceutical firms, Dr. Mazen Abu Samha.
According to a ministry statement Thursday, Hawari said that
the ministry seeks to develop drug studies and scientific research to improve
health services provided to citizens. He said that the memorandum is an
important indication of the ministry's belief in the partnership approach
between the public and private sectors across all fields, especially in
development and research.
For his part, Batayneh praised the importance of the joint
message issued by health care and pharmaceutical institutions promoting the
right of access to medicines for all, and the development of health care
services.
Dr. Abu Samha stressed the need to increase the pace of
cooperation in an organized manner with clear objectives that contribute to
achieving tangible positive results for Jordanian patients by investing in
advanced health infrastructure in Jordan and ensuring excellence on a regional
and global level.
The 15 international pharmaceutical companies cooperate
under the umbrella of the American Chamber of Commerce in Jordan to improve
health care through partnership with the public sector to ensure equitable
access to innovative medicine and enable patients to live healthier and more
productive lives.
Read more National news